{"CVE Code": "CVE-2021-43935", "Description": "The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.", "NVD Link": "https://nvd.nist.gov/vuln/detail/CVE-2021-43935", "Vulnerability Categories": "Bypass;Gain privilege", "Affected Products": "\nBaxter\u00bbWelch Allyn Hscribe Holter Analysis System FirmwareVersions  from including (>=) 5.01andup to, including, (<=) 6.4.0cpe:2.3:o:baxter:welch_allyn_hscribe_holter_analysis_system_firmware:*:*:*:*:*:*:*:*Matching versionsWhen used together with:Baxter\u00bbWelch Allyn Hscribe Holter Analysis System\u00bbVersion:N/A\nBaxter\u00bbWelch Allyn Q-stress Cardiac Stress Testing System FirmwareVersions  from including (>=) 6.0.0andup to, including, (<=) 6.3.1cpe:2.3:o:baxter:welch_allyn_q-stress_cardiac_stress_testing_system_firmware:*:*:*:*:*:*:*:*Matching versionsWhen used together with:Baxter\u00bbWelch Allyn Q-stress Cardiac Stress Testing System\u00bbVersion:N/A\nBaxter\u00bbWelch Allyn Xscribe Cardiac Stress Testing System FirmwareVersions  from including (>=) 5.01andup to, including, (<=) 6.3.1cpe:2.3:o:baxter:welch_allyn_xscribe_cardiac_stress_testing_system_firmware:*:*:*:*:*:*:*:*Matching versionsWhen used together with:Baxter\u00bbWelch Allyn Xscribe Cardiac Stress Testing System\u00bbVersion:N/A\nBaxter\u00bbWelch Allyn Connex CardioVersions  from including (>=) 1.0.0andup to, including, (<=) 1.1.1cpe:2.3:a:baxter:welch_allyn_connex_cardio:*:*:*:*:*:*:*:*Matching versions\nBaxter\u00bbWelch Allyn Diagnostic Cardiology Suite\u00bbVersion:2.1.0cpe:2.3:a:baxter:welch_allyn_diagnostic_cardiology_suite:2.1.0:*:*:*:*:*:*:*Matching versions\nBaxter\u00bbWelch Allyn Rscribe Resting Ecg SystemVersions  from including (>=) 5.01andup to, including, (<=) 7.0.0cpe:2.3:a:baxter:welch_allyn_rscribe_resting_ecg_system:*:*:*:*:*:*:*:*Matching versions\nBaxter\u00bbWelch Allyn Vision Express Holter Analysis SystemVersions  from including (>=) 6.1.0andup to, including, (<=) 6.4.0cpe:2.3:a:baxter:welch_allyn_vision_express_holter_analysis_system:*:*:*:*:*:*:*:*Matching versions", "EPSS Score": "0.19% Probability of exploitation activity in the next 30 days\n~ 57 % Percentile, the proportion of vulnerabilities that are scored at or less", "EPSS History": "\n #  Date  Old EPSS Score  New EPSS Score  Delta (New - Old) \n 1  2024-12-17  0.21%  0.19%  -0.02 \n 2  2024-08-24  0.19%  0.21%  +0.02 \n 3  2024-07-15  0.19%  0.19%  0.00 \n 4  2023-07-08  0.19%  0.19%  +0.01 \n 5  2023-05-28  0.17%  0.19%  +0.02 \n 6  2023-03-07  0.89%  0.17%  -0.72 ", "CVSS Scores": "6.8", "CWE": [{"CWE_ID": "CWE-287 Improper Authentication", "CWE_link": "/cwe-details/287/Improper-Authentication.html"}, {"CWE_ID": "CWE-288 Authentication Bypass Using an Alternate Path or Channel", "CWE_link": "/cwe-details/288/Authentication-Bypass-Using-an-Alternate-Path-or-Channel.html"}], "Reference": [{"ref_link": "https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01", "ref_desc": "Hillrom Welch Allyn Cardio Products | CISAMitigation;Third Party Advisory;US Government Resource", "ref_cve_link": "N/A"}]}